Tumor suppressor p53 induces miR-1915 processing to inhibit Bcl-2 in the apoptotic response to DNA damage

Kazuya Nakazawa1, Nurmaa Dashzeveg, Kiyotsugu Yoshida

  • 1Department of Biochemistry, The Jikei University School of Medicine, Tokyo, Japan; Medical Research Institute, Tokyo Medical and Dental University, Japan.

The FEBS Journal
|May 13, 2014
PubMed

Insights

The tumor suppressor p53 regulates miR-1915 processing in response to DNA damage. This mechanism controls the expression of the antiapoptotic protein Bcl-2, impacting cancer drug resistance.

Area of Science:

  • Molecular biology
  • Cancer research
  • Gene regulation

Background:

  • The antiapoptotic protein Bcl-2 is overexpressed in cancers, contributing to drug resistance.
  • The tumor suppressor p53 normally downregulates Bcl-2 following DNA damage, but the mechanism is unclear.
  • MicroRNA miR-1915 has been implicated in repressing Bcl-2 in colorectal cancer cells.

Purpose of the Study:

  • To elucidate the molecular mechanism by which p53 negatively regulates Bcl-2 expression.
  • To investigate the role of miR-1915 in the p53-mediated regulation of Bcl-2.
  • To understand the link between p53, miR-1915, and cancer drug resistance.

Main Methods:

  • Investigated p53's effect on miR-1915 expression in response to DNA damage.
  • Analyzed the impact of p53 induction on different forms of miR-1915 (primary, precursor, mature).
  • Assessed the effect of miR-1915 inhibition on Bcl-2 expression after genotoxic treatment.

Main Results:

  • p53 induction in response to DNA damage influences the expression of precursor and mature miR-1915, but not primary miR-1915.
  • Inhibiting miR-1915 prevents the downregulation of Bcl-2 expression following genotoxin treatment.
  • p53 targets the processing of miR-1915 from its primary to precursor form.

Conclusions:

  • p53 negatively regulates Bcl-2 expression through the modulation of miR-1915 processing.
  • This novel pathway involving p53 and miR-1915 offers new insights into cancer drug resistance mechanisms.
  • Understanding this regulatory axis could lead to improved therapeutic strategies for Bcl-2-overexpressing cancers.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K